Ladenburg Thalmann Financial Services’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,526	Closed	-$191K	–	5329
2017 Q4	$191K	Buy	3,526 +218	+7%	+$11.9K	﹤0.01%	2241
2017 Q3	$190K	Sell	3,308 -443	-12%	-$25.9K	﹤0.01%	2154
2017 Q2	$227K	Sell	3,751 -151	-4%	-$8.6K	﹤0.01%	1921
2017 Q1	$213K	Buy	+3,902	New	+$192K	﹤0.01%	1867

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BIVV Position: Q1 2018 in Review

Ladenburg Thalmann Financial Services sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,526 shares — an estimated $191K sold.

Ladenburg Thalmann Financial Services first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $227K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Ladenburg Thalmann Financial Services reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 3,526 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $191K.
Ladenburg Thalmann Financial Services first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Ladenburg Thalmann Financial Services's Bioverativ Inc. Common Stock position peaked at $227K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2018, filed 15 May 2018.